Page last updated: 2024-08-23

bezafibrate and Cirrhosis, Liver

bezafibrate has been researched along with Cirrhosis, Liver in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Abdelrahman, AM; El-Tahawy, NF; Ibrahim, SA; Mohamed, MZ1
Ohmoto, K; Yamamoto, S; Yoshioka, N1
Enzan, H; Ogawa, Y; Onishi, S; Saibara, T; Yoshida, S1

Other Studies

3 other study(ies) available for bezafibrate and Cirrhosis, Liver

ArticleYear
Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats.
    Canadian journal of physiology and pharmacology, 2021, Volume: 99, Issue:3

    Topics: Actins; Animals; Bezafibrate; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Liver Function Tests; Male; Malondialdehyde; Nitrites; Pioglitazone; Rats; Thioacetamide

2021
Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis.
    Journal of gastroenterology, 2006, Volume: 41, Issue:5

    Topics: Administration, Oral; Adult; Aged; Bezafibrate; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged

2006
Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.
    Lancet (London, England), 1999, May-22, Volume: 353, Issue:9166

    Topics: Antineoplastic Agents, Hormonal; Bezafibrate; Breast Neoplasms; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis; Tamoxifen

1999